Editorial: the immunogenicity to second anti-TNF therapy (IMSAT) therapeutic drug monitoring study-defining the risk of the in-class switch

被引：0
|
作者：
Wilson, Aze Suzanne [1 ,2 ,3 ]
机构：
[1] Western Univ, Dept Med, Div Clin Pharmacol, London, ON, Canada
[2] Western Univ, Div Gastroenterol, Dept Med, London, ON, Canada
[3] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 56卷 / 08期
关键词：
INFLIXIMAB; ANTIBODIES;
D O I：
10.1111/apt.17188
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1294 / 1295
页数：2
相关论文
共 25 条
  • [1] Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
    Chanchlani, Neil
    Lin, Simeng
    Auth, Marcus K.
    Lee, Chai Leng
    Robbins, Helena
    Looi, Shi
    Murugesan, Senthil, V
    Riley, Tom
    Preston, Cathryn
    Stephenson, Sophie
    Cardozo, Wendy
    Sonwalkar, Sunil A.
    Allah-Ditta, Mohammed
    Mansfield, Lynne
    Durai, Dharmaraj
    Baker, Mark
    London, Ian
    London, Emily
    Gupta, Sanjay
    Di Mambro, Alex
    Murphy, Aisling
    Gaynor, Edward
    Jones, Kelsey D. J.
    Claridge, Andrew
    Sebastian, Shaji
    Ramachandran, Sankaranarayanan
    Selinger, Christian P.
    Borg-Bartolo, Simon P.
    Knight, Paul
    Sprakes, Michael B.
    Burton, Julie
    Kane, Patricia
    Lupton, Stephanie
    Fletcher, Aimee
    Gaya, Daniel R.
    Colbert, Roghan
    Seenan, John Paul
    MacDonald, Jonathan
    Lynch, Lucy
    McLachlan, Iain
    Shields, Stephanie
    Hansen, Richard
    Gervais, Lisa
    Jere, Mwansa
    Akhtar, Muhammad
    Black, Karen
    Henderson, Paul
    Russell, Richard K.
    Lees, Charlie W.
    Derikx, Lauranne A. A. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1250 - 1263
  • [2] IMMUNOGENICITY TO SECOND ANTI-TNF THERAPY (IMSAT): IMPLICATIONS FOR SEQUENCING OF BIOLOGIC THERAPY
    Chanchlani, Neil
    Lin, Simeng
    Thomas, Amanda
    Hamilton, Ben
    Nice, Rachel
    Chee, Desmond
    Kennedy, Nick
    Goodhand, James
    Ahmad, Tariq
    GUT, 2021, 70 : A31 - A32
  • [3] Immunogenicity to second anti-TNF therapy (IMSAT): Implications for sequencing of biologic therapy
    Chanchlani, N.
    Lin, S.
    Thomas, A.
    Hamilton, B.
    Nice, R.
    Chee, D.
    Kennedy, N.
    Goodhand, J.
    Ahmad, T.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S097 - S098
  • [4] Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Frank I. Scott
    Gary R. Lichtenstein
    Current Treatment Options in Gastroenterology, 2014, 12 (1) : 59 - 75
  • [5] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [6] Editorial: is it time for therapeutic drug monitoring of anti-TNF agents during pregnancy? Maybe, maybe not
    Kane, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (12) : 1555 - 1556
  • [7] Editorial: therapeutic drug monitoring for anti-TNF agents-has it all been said?
    Domenech, E.
    Canete, F.
    Manosa, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (11-12) : 1113 - 1114
  • [8] Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (05): : 673 - 676
  • [9] Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease
    Bernardo, S.
    Fernandes, S.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S308 - S309
  • [10] A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Grossberg, Laurie B.
    Papamichael, Konstantinos
    Feuerstein, Joseph D.
    Siegel, Corey A.
    Ullman, Thomas A.
    Cheifetz, Adam S.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (01) : 191 - 197
123